To Top

Community

Greg Flyte

Greg Flyte is the Director of Contract Manufacturing Organization (CMO) Alliance & Program Management at GlaxoSmithKline (GSK). He brings over 18 years of technical and business experience in engineering, validation, process development, alliance/ program/project management, manufacturing operations, and business development. In his current role, he is responsible for the contract development and manufacturing organization (CDMO) business, including several collaborations with both small and large biopharmaceutical companies who are current clients of GSK. During his sixteen years at the Rockville, Maryland, USA site (14 with Human Genome Sciences which was acquired by GSK in August 2012). Greg has also been involved with managing the design through validation phases during the construction of all GSK’s manufacturing facilities, in addition to managing the large scale manufacturing (LSM) facility validation team from inception through commercial production. Prior to joining HGS, Greg spent two years as a validation engineer consultant. He holds a B.S. in Chemical Engineering from Drexel University.

Contribution

Putting the “D” in CDMO with Advanced Process Development

PAP-Q1-16-CL-002

Risk Minimization through Careful CDMO Selection

PAP-Q4-15-CL-003
CDMO

Four Keys to Successful Biopharmaceutical Outsourcing: Technical Expertise, Quality, Reliability and Timeliness

PAP-APR-S01-CL-001